Connection

VIKAS KUNDRA to Apoptosis

This is a "connection" page, showing publications VIKAS KUNDRA has written about Apoptosis.
Connection Strength

0.073
  1. Tumor T1 Relaxation Time for Assessing Response to Bevacizumab Anti-Angiogenic Therapy in a Mouse Ovarian Cancer Model. PLoS One. 2015; 10(6):e0131095.
    View in: PubMed
    Score: 0.048
  2. Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases. Sci Transl Med. 2014 Sep 03; 6(252):252ra122.
    View in: PubMed
    Score: 0.011
  3. Pharmacodynamic markers of perifosine efficacy. Clin Cancer Res. 2007 Dec 15; 13(24):7421-31.
    View in: PubMed
    Score: 0.007
  4. The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human non-small-cell lung cancer cells. Cancer Res. 2006 Oct 01; 66(19):9682-90.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.